219 related articles for article (PubMed ID: 32799200)
1. Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.
Miyakita H; Sadahiro S; Suzuki T; Chan LF; Ogimi T; Okada K; Yamamoto S; Kajiwara H
Oncology; 2020; 98(12):869-875. PubMed ID: 32799200
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
[TBL] [Abstract][Full Text] [Related]
3. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.
Matsutani S; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Hirakawa K; Ohira M
Cancer Sci; 2018 Apr; 109(4):966-979. PubMed ID: 29464828
[TBL] [Abstract][Full Text] [Related]
4. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
[TBL] [Abstract][Full Text] [Related]
5. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte nadir predicts tumor response and survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Immunologic relevance.
Liu H; Wang H; Wu J; Wang Y; Zhao L; Li G; Zhou M
Radiother Oncol; 2019 Feb; 131():52-59. PubMed ID: 30773187
[TBL] [Abstract][Full Text] [Related]
7. Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.
McCoy MJ; Hemmings C; Anyaegbu CC; Austin SJ; Lee-Pullen TF; Miller TJ; Bulsara MK; Zeps N; Nowak AK; Lake RA; Platell CF
Oncotarget; 2017 Mar; 8(12):19803-19813. PubMed ID: 28177891
[TBL] [Abstract][Full Text] [Related]
8. Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer.
Huang Y; Lou XY; Zhu YX; Wang YC; Zhang L; Liu HL; Wang C; Zhan HM; Cheng ZQ; Tan WY; Wang L; Fan XJ
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30867256
[TBL] [Abstract][Full Text] [Related]
9. [Effects of neoadjuvant chemoradiotherapy on infiltrating immune cells in the tumor microenvironment of rectal cancer].
Yang Q; Zhou C; Han C; Zhang Y; Jiang Y; Li Z; Ma J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1270-1276. PubMed ID: 34549721
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment Mediators CD8
Zaghloul H; Abbas A; Abdulah D
J Gastrointest Cancer; 2021 Mar; 52(1):177-186. PubMed ID: 32112202
[TBL] [Abstract][Full Text] [Related]
11. High CD8
Koemans WJ; van Dieren JM; van den Berg JG; Meijer GA; Snaebjornsson P; Chalabi M; Lecot F; Riedl R; Krijgsman O; Hofland I; Broeks A; Voncken FEM; Peppelenbosch MP; Sosef MN; van Sandick JW; Kodach LL
Histopathology; 2021 Aug; 79(2):238-251. PubMed ID: 33660299
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy.
Chen TW; Huang KC; Chiang SF; Chen WT; Ke TW; Chao KSC
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1043-1053. PubMed ID: 30874889
[TBL] [Abstract][Full Text] [Related]
13. Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Saito G; Kamijo A; Akiba T; Kawada S
Int J Clin Oncol; 2015 Dec; 20(6):1130-9. PubMed ID: 25833701
[TBL] [Abstract][Full Text] [Related]
14. Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density.
Xu Y; Lou X; Liang Y; Zhang S; Yang S; Chen Q; Xu Z; Zhao M; Li Z; Zhao K; Liu Z
J Inflamm Res; 2021; 14():5891-5899. PubMed ID: 34785927
[TBL] [Abstract][Full Text] [Related]
15. Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer.
Imaizumi K; Suzuki T; Kojima M; Shimomura M; Sakuyama N; Tsukada Y; Sasaki T; Nishizawa Y; Taketomi A; Ito M; Nakatsura T
Cancer Sci; 2020 Jan; 111(1):23-35. PubMed ID: 31660687
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
17. [Changes in the CD8+ Density of Tumor Infiltrating Lymphocytes after Neoadjuvant Radiochemotherapy in Patients with Rectal Adenocarcinom].
Buka D; Dvořák J; Sitorová V; Hátlová J; Richter I; Sirák I
Klin Onkol; 2016; 29(3):204-9. PubMed ID: 27296405
[TBL] [Abstract][Full Text] [Related]
18. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
[TBL] [Abstract][Full Text] [Related]
19. T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer.
Akiyoshi T; Gotoh O; Tanaka N; Kiyotani K; Yamamoto N; Ueno M; Fukunaga Y; Mori S
Cancer Immunol Immunother; 2021 Feb; 70(2):509-518. PubMed ID: 32845355
[TBL] [Abstract][Full Text] [Related]
20. The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Tang JH; An X; Lin X; Gao YH; Liu GC; Kong LH; Pan ZZ; Ding PR
Oncotarget; 2015 Oct; 6(32):33919-25. PubMed ID: 26416245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]